| __timestamp | Dynavax Technologies Corporation | MorphoSys AG |
|---|---|---|
| Wednesday, January 1, 2014 | 17763000 | 9689000 |
| Thursday, January 1, 2015 | 22180000 | 10431000 |
| Friday, January 1, 2016 | 37257000 | 9618000 |
| Sunday, January 1, 2017 | 27367000 | 12348000 |
| Monday, January 1, 2018 | 64770000 | 28310241 |
| Tuesday, January 1, 2019 | 74986000 | 59336147 |
| Wednesday, January 1, 2020 | 79256000 | 159145941 |
| Friday, January 1, 2021 | 100156000 | 199800000 |
| Saturday, January 1, 2022 | 131408000 | 90225000 |
| Sunday, January 1, 2023 | 152946000 | 92538000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. This analysis compares the SG&A efficiency of MorphoSys AG and Dynavax Technologies Corporation from 2014 to 2023. Over this period, Dynavax's SG&A expenses surged by approximately 760%, peaking in 2023. In contrast, MorphoSys AG saw a more modest increase of around 850%, with a significant spike in 2020.
Understanding these trends can provide valuable insights into each company's strategic priorities and operational efficiency.
Selling, General, and Administrative Costs: Eli Lilly and Company vs MorphoSys AG
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Neurocrine Biosciences, Inc. and Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing Summit Therapeutics Inc. and Dynavax Technologies Corporation
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Selling, General, and Administrative Costs: MorphoSys AG vs HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Amphastar Pharmaceuticals, Inc.
MorphoSys AG and Evotec SE: SG&A Spending Patterns Compared
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Dynavax Technologies Corporation or BioCryst Pharmaceuticals, Inc.